Global Retirement Partners’s Insight Molecular Diagnostics IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$6 – 4983
2026
Q2
$6 Buy
+1
New +$5 ﹤0.01% 4503
2025
Q4
$8 Hold
1
– – ﹤0.01% 4213
2025
Q3
$3 Hold
1
– – ﹤0.01% 3860
2025
Q2
$3 Buy
+1
New +$3 ﹤0.01% 3797

Other funds holding IMDX

Global Retirement Partners's IMDX Position: Q3 2026 in Review

Global Retirement Partners sold out of Insight Molecular Diagnostics (IMDX) in Q3 2026, closing a stake of 1 share — an estimated $6 sold.

Global Retirement Partners first reported a position in IMDX in Q2 2025 and held it in 4 quarters. The position peaked at $8 in Q4 2025. 44 funds tracked by Wall St. Rank hold IMDX as of Q3 2026.

  • Global Retirement Partners reported no remaining Insight Molecular Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Global Retirement Partners sold 1 Insight Molecular Diagnostics share in Q3 2026, an estimated $6.
  • Global Retirement Partners first reported a position in Insight Molecular Diagnostics in Q2 2025 and held it in 4 quarters.
  • Global Retirement Partners's Insight Molecular Diagnostics position peaked at $8 in Q4 2025.
  • 44 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.